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Heart Rate Variability as a Possible Predictive Marker for Acute
Inflammatory Response in COVID-19 Patients
Frederick Hasty, MD*,†,‡,§ ; Guillermo García, MD*,†,‡,§ ;
COL Héctor Dávila, MD, MSS, MC, USAR (Ret.)*,†,‡,§ ; S. Howard Wittels, MD*,†,‡,§ ;
Stephanie Hendricks, BA; Stephanie Chong, DNP, CRNA, ARNP§,¶

Materials and Methods:
In accordance with an Institutional Review Board-approved study, 17 patients were followed using the wearable, noninvasive Tiger Tech Warfighter Monitor (WFM) that records HRV from a single limb electrocardiogram. Intermittent, daily
short-segment data sets of 5 to 7 minutes over a minimum of 7 days were analyzed. Changes in HRV were compared to
changes in CRP.
Results:
Decreases in HRV of greater than 40% preceded a 50% increase in CRP during the ensuing 72 hours in 10 of the 12
patients who experienced a dramatic rise in CRP. The effectiveness of HRV as a leading indicator of a rise in CRP was
evaluated; the sensitivity, specificity, positive predictive value, and negative predictive value for 40% decreases in HRV
preceding 50% increases in CRP were 83.3%, 75%, 90.9%, and 60%, respectively.
Conclusion:
Substantial decreases in HRV preceded elevations in CRP in the ensuing 72 hours with a 90.9% positive predictive
value. Early detection of increasing inflammation may prove vital in mitigating the deleterious effects of an abnormal
inflammatory response, particularly in COVID-19 patients. This capability could have a major impact in triage and care
of moderate to severe COVID-19 patients in major medical centers as well as field hospitals. This study demonstrates
the potential value of short-segment, intermittent HRV analysis in COVID-19 patients.

INTRODUCTION
COVID-19 patients requiring admission to an intensive care
unit represent the minority of cases but can follow a stormy
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course caused by a pathological inflammatory response, often
referred to as “Cytokine Storm”.1 Cytokine storm coincides
with a steep rise in inflammatory markers, such as C-reactive
protein (CRP). Hence, CRP helps clinicians decide when and
in whom pharmacological therapies, such as interleukin-6
inhibitors, might be instituted. However, a drawback to this
laboratory test is that it may not prompt clinicians to begin
therapy soon enough.
A readily available, noninvasive tool that may provide
early warning of impending cytokine storm involves analysis
of the cadence of cardiac cycles. Heart rate variability (HRV)
is a physiological metric, regulated by the autonomic nervous
system (ANS), that has been used for decades to evaluate general well-being in various clinical settings.2 Because the ANS
responds quickly to changes in physiological states, it may
offer signals, in the form of HRV, that can warn of an impending cytokine storm sooner than other currently employed laboratory tests. It is probable that earlier recognition of clinical
deterioration, by triggering earlier therapeutic interventions,
could better the chance of positive outcomes. However, the
ability to extract, analyze, and calculate HRV from our standard hospital monitors was impossible for this study. Our
standard hospital monitors are not technically set-up for HRV
analysis because of the challenge of extracting the necessary
electrocardiogram (ECG) data for HRV calculations.
MILITARY MEDICINE, Vol. 186, January/February 2021
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ABSTRACT
Introduction:
Increases in C-reactive protein (CRP) are used to track the inflammatory process of COVID-19 and are associated with
disease state progression. Decreases in heart rate variability (HRV) correlate with worsening of disease states. This
observational study tracks changes in HRV relative to changes in CRP in COVID-19 patients.

HRV and Acute Inflammatory Response in COVID-19
TABLE I. Patient Demographics and Characteristics
Mean age (SD) and range

60.5 years (13.4) 31–85

Comorbidities

Sex
Ethnicity

71%
53%
29%
6%
12%
32.1 (6.5) 23–42

71%
24%
35%
6%
12%
29%

Mean BMI (SD) and range

Male
Hispanic
African American
Asian American
Caucasian

METHODS
Patients
After obtaining approval and waiver of consent from
Mount Sinai Medical Center Institutional Review Board, we
recruited patients admitted to this facility from April 9 through
May 8, 2020. Inclusion criteria were patients 18 years or
older with polymerase chain reaction-positive nasopharyngeal swabs for SARS-CoV-2 admitted to the COVID ICU and
step-down units for a minimum of 7 days. All patients presented with hypoxic respiratory failure requiring high-flow
nasal cannula or mechanical ventilation. Excluded patients
included those who refused to participate, were in rotobeds, on extracorporeal membrane oxygenation, or in hospice.
Seventeen patients were enrolled as a random convenience
sample. These were nonsequential patients. Measurements
of HRV and CRP were made on each patient over a minimum of 7 days to provide sufficient time to observe trends.
MILITARY MEDICINE, Vol. 186, January/February 2021

Patient demographic data and comorbidities are summarized
in Table I.
Data Collection
The research personnel donned all appropriate personal protective equipment throughout the time they were in the
patient’s room. A wearable monitoring device was used
to measure heart rate and HRV from a single limb ECG
attributable to the lack of HRV analysis capabilities of our
standard ICU monitors. The device selected for data collection was the Tiger Tech Warfighter Monitor (Miami, FL)8
as shown in Fig. 1. As a result of limitations of resources
and exposure risk, short-segment HRV data sets were collected over 7 minutes (a time window sufficient to gather ECG
baseline readings and to analyze HRV).9 Measurements were
taken in the morning to eliminate diurnal variation. A designated, secure phone received and archived the data from the
Warfighter Monitor via Bluetooth. When not in use for the
study, the phone was kept in a secured site on Mount Sinai
Medical Center campus. Heart rate variability was calculated
using the standard deviation of the NN interval (SDNN).
A large, 3M Tegaderm (St. Paul, MN) was placed on the
lateral aspect of the bicep to prevent contamination of the
device. The device was then placed on top of the Tegaderm
and secured to the patient with a second Tegaderm. At the
completion of the 7-minute reading, the device was removed
from the patient and thoroughly decontaminated with 70%
Alcohol Metrex CaviWipes (Orange, CA). The Tegaderm was
removed from the patient and the researchers doffed their
personal protective equipment.
RESULTS
Of the 17 patients studied, data from one patient were too
inconsistent to analyze and are not discussed further here.
Of the remaining 16 patients, 12 developed a greater than
50% increase in CRP during the study period. Of the 12
patients who developed a greater than 50% increase in CRP,
10 demonstrated a greater than 40% drop in HRV within a
72-hour window preceding the increase in CRP. An example of the temporal relationship between HRV and CRP
recorded from one patient over several days is shown in Fig. 2.
Fig. 2 plots on the same abscissa CRP as mg/dL with respect
to the left ordinate and HRV as SDNN with respect to the right
ordinate.
e35
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The relation between HRV and inflammatory states has
been extensively studied. A recent meta-analysis of over
51 studies encompassing a total of 2,238 patients demonstrated an inverse relationship between HRV and inflammation.3 However, a precise mechanism for how the immune
system and the ANS interact to impact the HRV has not
been described.4 A common measure of HRV is the standard
deviation of the interval between heartbeats (SDNN). This
measure of HRV has been shown to correlate inversely with
the nonspecific inflammatory marker CRP.4
In the current COVID-19 pandemic, CRP has become
vital to monitoring patients’ inflammatory status.5 Clinicians
across the globe are using CRP to stratify and predict disease
severity in COVID-19.6 Large rises in CRP and interleukin-6
coincide with cytokine storm and with the progression to more
severe disease states.1 Interleukin-6 levels, while more specific to cytokine storm,7 often require blood samples to be sent
to specialized laboratories, resulting in extended turn-around
times for results. C-reactive protein levels, on the other hand,
are readily available for most hospital clinicians. Therefore,
physicians in the community follow CRP values to determine
the onset of this hyper-inflammatory state. Current literature
has found elevated CRP to be an independent factor predicting disease risk and correlating with disease severity.5,6 In the
present study, we set out to determine whether decreases in
HRV predict elevations in CRP in COVID-19 patients.

Cardiovascular disease
Pulmonary disease
Renal disease
Immunocompromised
Previous or current cancer
Diabetic

HRV and Acute Inflammatory Response in COVID-19

FIGURE 2. An example of one patient’s biometrics over time. The charted
lines represent heart rate variability in a triangulated line and C-reactive protein (CRP) in a blocked line. A drop of more than 40% in standard deviation
of the interval between heartbeats (SDNN) is followed by more than a tripling
of CRP in the subsequent 72 hours.

The data collection in Fig. 2 begins on April 13. A characteristic decrease in HRV is demonstrated from April 20 to
April 23 which is followed by the rise in CRP from April
23 to April 26. This is representative of the findings in 10 of
the 12 patients who had an increase in CRP. As with all of the
patients studied, the relationship between HRV and CRP at the
beginning and end of the studies could not be completely analyzed because the preceding HRV and subsequent CRP levels
were not recorded. However, during the study period, we
e36

DISCUSSION
In this study, we tracked HRV and CRP changes in 16
COVID-19 patients. In this small series, 75% of patients experienced a dramatic rise in CRP during the study period. In
those patients, we found a threshold decrease (>40%) in HRV
to be 83.3% sensitive and 75% specific for subsequent significant rises in CRP. Furthermore, our PPV and NPV were
90.9% and 60%, respectively. This threshold yielded the optimum PPV and NPV while maintaining the highest sensitivity
and specificity. We did not find a similar relationship when
using absolute values for changes in HRV. Further studies are
required to explain the temporal relationship between HRV
and CRP.
Of the 12 patients who demonstrated large rises in CRP, 2
did not demonstrate decreases in HRV. Of these, one patient
received convalescent plasma the day before the surge in CRP
(<2.5 to 63 mg/dL in 24 hours). The second patient was in
a convalescent stage when her CRP rose >50% in 48 hours
while her clinical condition remained unchanged.
In the 10 patients who demonstrated dramatic decreases
in HRV with subsequent increases in CRP, the clinical significance varied. All 10 had severe infections with hypoxic
respiratory failure and required a minimum of high-flow nasal
cannula during the study period. Two did not require intubation. One non-intubated patient who progressed from severe
to mild disease demonstrated a large decrease in HRV with
a subsequent large increase in CRP which appeared to be
of no clinical significance. A second non-intubated patient
MILITARY MEDICINE, Vol. 186, January/February 2021
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FIGURE 1. The Warfighter Monitor measures heart rate and heart rate
variability from a single limb electrocardiogram.

consistently found a correlation between a >40% decrease in
HRV and subsequent 50% rise in CRP.
The consistency of the relation between the drop in HRV
preceding the rise in CRP is examined in the 2 by 2 contingency matrix presented as Table II. The upper pair of cells in
the matrix presents the number of patients with the decrease in
HRV of more than 40% while the lower pair of cells presents
the number of patients with no such HRV decrease. The left
half of the table presents the number of patients in which CRP
increased by more than 50% while the right half of the table
presents the number of patients in which no such increase
occurred.
From this table, it is possible to assess the usefulness of
HRV as a leading indicator for an increase in CRP, at least for
the present dataset. Thus, the number of HRV true positive
over the total number of CRP increases showed that HRV had
a calculated leading indicator sensitivity of 83.3%. Moreover,
HRV is specific to the CRP increase since the HRV decrease
did not occur without a subsequent CRP increase three out
of four times, producing a calculated leading indicator specificity of 75%. Furthermore, from these data, 90.9% of the
time the HRV decrease was associated with the CRP increase,
termed “positive predictive value” (PPV); whereas 60% of the
time the absence of an HRV decrease was associated with
the absence of the CRP increase, termed “negative predictive
value” (NPV).

HRV and Acute Inflammatory Response in COVID-19
TABLE II. Calculations of Sensitivity, Specificity, Positive Predictive Value, and Negative Predictive Value

HRV
decreases
>40%
HRV
unchanged

CRP increases > 50%

CRP does not change

True positive (TP)a
10

False positives (FP)b
1

Positive predictive value
90.9% [=10/11*100]

False negatives (FN)c
2
Sensitivity
83.3% [=10/12*100]

True negatives (TN)d
3
Specificity
75% [=3/4*100]

Negative predictive value
60% [=3/5*100]

a ↓HRV

40% followed by ↑CRP 50% (within 72 hours).
without ↑CRP.
c ↑CRP without a >40% ↓HRV.
d No ↓HRV 40% nor ↑CRP.
b ↓HRV > 40%

MILITARY MEDICINE, Vol. 186, January/February 2021

advantageous to combatting or even preventing a cytokine
storm. Because it can be difficult to predict which patients will
need anti-inflammatory interventions, short-segment HRV
metrics in COVID-19 patients may prove to be a noninvasive leading indicator aid for triage and subsequent treatment
throughout the disease course.
CONCLUSIONS
Dramatic drops in HRV correlated with subsequent spikes in
CRP in COVID-19 patients. Daily short-segment HRV readings may aid clinicians in the triage, disease progress monitoring, and treatment. Intermittent HRV analysis could provide
an early warning of an impending inflammatory response
(e.g., cytokine storm). Furthermore, this capability could have
a major impact in the care of moderate to severe COVID-19
patients in major medical centers, as well as field hospitals.
Larger, prospective, randomized, multisite-controlled trials
are needed to evaluate the potential value of HRV in the management of COVID-19 patients throughout the course of their
hospitalizations.
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